Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review

Mademont-Soler, I., Morales, C., Clusellas, N., Soler, A., Sánchez, A.: Group of cytogenetics from Hospital Clínic de Barcelona: prenatal cytogenetic diagnosis in Spain: analysis and evaluation of the results obtained from amniotic fluid samples during the last decade. Eur. J. Obstet. Gynecol. Reprod. Biol. 157, 156–160 (2011)

Mai, C.T., Kucik, J.E., Isenburg, J., Feldkamp, M.L., Marengo, L.K., Bugenske, E.M., et al.: Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006–2010: featuring trisomy conditions. Birth Defects Res. Part A Clin. Mol. Teratol. 97, 709–725 (2013)

Benn, P., Borrell, A., Crossley, J., Cuckle, H., Dugoff, L., Gross, S., et al.: Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 31, 519–522 (2011)

Allyse, M., Minear, M.A., Berson, E., Sridhar, S., Rote, M., Hung, A., et al.: Non-invasive prenatal testing: a review of international implementation and challenges. Int. J. Womens Health 7, 113–126 (2015)

Gil, M.M., Quezada, M.S., Revello, R., Akolekar, R., Nicolaides, K.H.: Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet. Gynecol. 45, 249–266 (2015)

Taylor-Phillips, S., Freeman, K., Geppert, J., Agbebiyi, A., Uthman, O.A., Madan, J., et al.: Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 6, e010002 (2016)

Mackie, F.L., Hemming, K., Allen, S., Morris, R.K., Kilby, M.D.: The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 124, 32–46 (2017)

Iwarsson, E., Jacobsson, B., Dagerhamn, J., Davidson, T., Bernabé, E., Heibert Arnlind, M.: Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population—a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 96, 7–18 (2017)

Dondorp, W., de Wert, G., Bombard, Y., Bianchi, D.W., Bergmann, C., Borry, P., et al.: European Society of Human Genetics; American Society of Human Genetics: non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur. J. Hum. Genet. 23, 1438–1450 (2015)

Khalifeh, A., Weiner, S., Berghella, V., Donnenfeld, A.: Trends in invasive prenatal diagnosis: effect of sequential screening and noninvasive prenatal testing. Fetal Diagn. Ther. 39, 292–296 (2016)

Drummond, M.F., Jefferson, T.O.: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ economic evaluation working party. BMJ 313, 275–283 (1996)

Welte, R., Feenstra, T., Jager, H., Leidl, R.: A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics 22, 857–876 (2004)

Shemilt, I., Thomas, J., Morciano, M.: A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy 6, 51–59 (2010)

CCEMG—EPPI-Centre Cost, Converter v. 1.5 [database in Internet] [London]: The Campbell and Cochrane Economics Methods Group (CCEMG) and the Evidence for Policy and Practice Information and Coordinating Centre (EPPI-Centre). http://eppi.ioe.ac.uk/costconversion (2016). Accessed 10 May 2017

Ayres, A.C., Whitty, J.A., Ellwood, D.A.: A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program. Aust. N. Z. J. Obstet. Gynaecol. 54, 412–417 (2014)

Beulen, L., Grutters, J.P., Faas, B.H., Feenstra, I., van Vugt, J.M., Bekker, M.N.: The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 182, 53–61 (2014)

Chitty, L.S., Wright, D., Hill, M., Verhoef, T.I., Daley, R., Lewis, C., et al.: Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. BMJ 354, i3426 (2016)

Fairbrother, G., Burigo, J., Sharon, T., Song, K.: Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis. J. Matern. Fetal Neonatal Med. 29, 1160–1164 (2016)

Garfield, S.S., Armstrong, S.O.: Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies. J. Manag. Care Med. 15, 34–41 (2012)

Gyselaers, W., Hulstaert, F., Neyt, M.: Contingent non-invasive prenatal testing: an opportunity to improve non-genetic aspects of fetal aneuploidy screening. Prenat. Diagn. 35, 1347–1352 (2015)

Hulstaert, F., Neyt, M., Gyselaers, W.: The non-invasive prenatal test (NIPT) for trisomy 21—health economic aspects. Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE). 2014. KCE Reports 222. D/2014/10.273/36

Morris, S., Karlsen, S., Chung, N., Hill, M., Chitty, L.S.: Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down’s syndrome using cell free fetal DNA in the UK National Health Service. PLoS One 9, e93559 (2014)

Neyt, M., Hulstaert, F., Gyselaers, W.: Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open 4, e005922 (2014)

Okun, N., Teitelbaum, M., Huang, T., Dewa, C.S., Hoch, J.S.: The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada. Prenat. Diagn. 34, 350–356 (2014)

O’Leary, P., Maxwell, S., Murch, A., Hendrie, D.: Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies. Aust. N. Z. J. Obstet. Gynaecol. 53, 425–433 (2013)

Song, K., Musci, T.J., Caughey, A.B.: Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J. Matern. Fetal Neonatal. Med. 26, 1180–1185 (2013)

Walker, B.S., Jackson, B.R., LaGrave, D., Ashwood, E.R., Schmidt, R.L.: A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat. Diagn. 35, 440–446 (2015)

Walker, B.S., Nelson, R.E., Jackson, B.R., Grenache, D.G., Ashwood, E.R., Schmidt, R.L.: A cost-effectiveness analysis of first trimester non-invasive prenatal screening for fetal trisomies in the United States. PLoS One 10, e0131402 (2015)

Nelson, A.L., Cohen, J.T., Greenberg, D., Kent, D.M.: Much cheaper, almost as good: decrementally cost-effective medical innovation. Ann. Intern. Med. 151, 662–667 (2009)

Cuckle, H., Benn, P., Pergament, E.: Maternal cfDNA screening for Down syndrome–a cost sensitivity analysis. Prenat. Diagn. 33, 636–642 (2013)

Ohno, M., Caughey, A.: The role of noninvasive prenatal testing as a diagnostic versus a screening tool—a cost-effectiveness analysis. Prenat. Diagn. 33, 630–635 (2013)

Gil, M.M., Quezada, M.S., Bregant, B., Syngelaki, A., Nicolaides, K.H.: Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn. Ther. 35, 204–211 (2014)

Bevilacqua, E., Gil, M.M., Nicolaides, K.H., Ordoñez, E., Cirigliano, V., Dierickx, H., et al.: Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet. Gynecol. 45, 61–66 (2015)

Sarno, L., Revello, R., Hanson, E., Akolekar, R., Nicolaides, K.H.: Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy. Ultrasound Obstet. Gynecol. 47, 705–711 (2016)

de Jong, A., Maya, I., van Lith, J.M.: Prenatal screening: current practice, new developments, ethical challenges. Bioethics 29, 1–8 (2015)

Benn, P., Borrell, A., Chiu, R.W., Cuckle, H., Dugoff, L., Faas, B., et al.: Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 35, 725–734 (2015)

Kotsopoulou, I., Tsoplou, P., Mavrommatis, K., Kroupis, C.: Non-invasive prenatal testing (NIPT): limitations on the way to become diagnosis. Diagnosis 2, 141–158 (2015)